Clinical trials recruiting for Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
Fewer than 3 recruiting trials found.
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Cyclophosphamide | 1 |
| Devimistat | 1 |
| Fluorouracil | 1 |
| Gemcitabine Hydrochloride | 1 |
| Hydroxychloroquine | 1 |
| Neoantigen Peptide Vaccine | 1 |
| Pembrolizumab | 1 |
| Sargramostim | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 1 |
| Illinois | 1 |
Top cities
Self-screener
Recruiting trials
- CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Related conditions
Trials recruiting for Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.